Dolores Calicchio

Dolores Calicchio

Personalreferent bei Noven Pharmaceuticals, Inc.

Health Technology

Ursprung des Netzwerks ersten Grades von Dolores Calicchio

EinheitArt der EinheitIndustrie
17
Subsidiary Pharmaceuticals: Major 17

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Dolores Calicchio

UnternehmenSektorVerknüpfte PersonenHauptposition
BAXTER INTERNATIONAL INC. Medical Specialties

Krista Roberts

Corporate Officer/Principal

CARDINAL HEALTH, INC. Medical Distributors

Lance D. Williams

Human Resources Officer

Pharmaceuticals: Major

Joseph C. Jones

Public Communications Contact

PFIZER, INC. Pharmaceuticals: Major

Bruce C. Friedman

Corporate Officer/Principal

GENEREX BIOTECHNOLOGY CORPORATION Pharmaceuticals: Major

Peter G. Amanatides

Director/Board Member

ACUSPHERE, INC. Pharmaceuticals: Major

Patrick Gallagher

Corporate Officer/Principal

RADIUS HEALTH, INC. Biotechnology

Scott Briggs

Chief Executive Officer

Internet Software/Services

Scott Briggs

Chief Operating Officer

Aluminum

Lance D. Williams

Human Resources Officer

College/University

Joel S. Lippman

Graduate Degree

University of Pennsylvania College/University

Patrick Gallagher

Masters Business Admin

HISAMITSU PHARMACEUTICAL CO., INC. Pharmaceuticals: Major

Toshiaki Tsuruda

Kyu Saito

Naruhito Higo

Director/Board Member

Director/Board Member

Director/Board Member

MARUTO SANGYO CO., LTD. Containers/Packaging

Toshiaki Tsuruda

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Jeff T. Mihm

Joseph C. Jones

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Joel S. Lippman

Corporate Officer/Principal

Hood College College/University

Peter G. Amanatides

Graduate Degree

LaSalle University College/University

Patrick Gallagher

Undergraduate Degree

University of Kansas College/University

Snehal Shah

Doctorate Degree

Medical Specialties

Joel S. Lippman

Chief Tech/Sci/R&D Officer

Villanova University College/University

Scott Briggs

Undergraduate Degree

Pharmaceuticals: Major

Anthony Venditti

Corporate Officer/Principal

New York Medical College College/University

Joel S. Lippman

Doctorate Degree

Pharmaceuticals: Major

Bruce C. Friedman

Scott Briggs

Jeff T. Mihm

Corporate Officer/Principal

Sales & Marketing

Chief Executive Officer

Chemicals: Major Diversified

Peter G. Amanatides

Director/Board Member

Regent's Business School London College/University

Peter G. Amanatides

Undergraduate Degree

Pharmaceuticals: Major

Joel S. Lippman

Corporate Officer/Principal

Pharmalogika, Inc.

Peter G. Amanatides

President

IVERIC BIO, INC. Pharmaceuticals: Generic

Snehal Shah

General Counsel

SHD Strategic LC

Joseph C. Jones

President

Pharmaceuticals: Major

Juan A. Mantelle

Chief Tech/Sci/R&D Officer

PACO Research Corp.

Juan A. Mantelle

Corporate Officer/Principal

Industrial Machinery

Anthony Venditti

Corporate Officer/Principal

Pharmaceuticals: Other

Naruhito Higo

President

Pharmaceuticals: Major

Toshiaki Tsuruda

Director/Board Member

Miscellaneous Commercial Services

Kyu Saito

Chairman

Pharmaceuticals: Other

Kyu Saito

Chairman

Sanofi-Hisamitsu KK

Kyu Saito

Director/Board Member

Medical Specialties

Kyu Saito

Director/Board Member

Medical Distributors

Kyu Saito

Naruhito Higo

President

President

Rutgers University- Newark College/University

Snehal Shah

Undergraduate Degree

Pharmaceuticals: Major

Kyu Saito

Chairman

Hisamitsu Pharmaceutical (Hong Kong) Co., Ltd.

Kyu Saito

Chairman

Biotechnology

Jeff T. Mihm

Director/Board Member

Statistik

International

Vereinigte Staaten 40
Japan 5
Vereinigtes Königreich 3
China 3
Mexiko 2

Sektoral

Health Technology 25
Consumer Services 10
Distribution Services 3
Technology Services 3
Process Industries 3

Operativ

Corporate Officer/Principal 26
Director/Board Member 19
President 7
Chief Tech/Sci/R&D Officer 7
General Counsel 6
  1. Börse
  2. Insiders
  3. Dolores Calicchio
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT